|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01218815 |
|
Date of registration:
|
01/10/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Complete Infarct Related Artery Revascularization
CORAMI |
|
Scientific title:
|
Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Patients - CORAMI Trial |
|
Date of first enrolment:
|
October 2010 |
|
Target sample size:
|
1 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT01218815 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Poland
|
Slovenia
| | | | | | |
|
Contacts
|
|
Name:
|
Dariusz Dudek, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Interventional Cardiology, Jagiellonian University Medical College in Krakow, Poland |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosis of STEMI (according to ESC 2007 definition)
- Chest pain onset <12 hours
- signed informed consent
- Presence of two critical lesions requiring PCI in IRA (LAD - left anterior descending, Cx - circumflex, RCA - right coronary artery)
- Target/culprit lesion which requires immediate stenting (>50 - 100%) and second critical lesion (70-90%) with TIMI 3 flow after PCI of the 1st target/culprit lesion
- Over 18 years of age
- IRA diameter = 2.5 mm
Exclusion Criteria:
- Terminal illness with life expectancy less <1 year or active cancer disease - Pregnancy or possibility of pregnancy
- Second critical lesion in IRA >90% or occlusion
- Contraindications to PCI or/and stent implantation
- Contraindications to DES stent implantation
- Lesion diameters unsuitable for intended stent platform
- Active bleeding or coagulopathy
- Patient in cardiogenic shock (<90mmHg SBP and/or requiring IABP - intraaortic balloon pump - or vasopressors) - Killip 4 class
- Patient has Left Bundle Branch Block (LBBB) or pacemaker rhythm
- No future patient cooperation expected
- Patient is participating in another clinical study
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary Artery Disease
|
|
Myocardial Infarction
|
|
Intervention(s)
|
|
Procedure: IRA stenting
|
|
Procedure: IRA stenting in culprit lesion only
|
|
Primary Outcome(s)
|
|
ST resolution in ECG (electrocardiogram) and MBG (myocardial blush grade)
[Time Frame: in-hospital directly after PCI]
|
|
Secondary Outcome(s)
|
|
Adverse events and complications during hospital stay
[Time Frame: during patient index hospitalization (up to 7 days)]
|
|
Clinical major ischemic events
[Time Frame: 12-months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|